{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:23:27Z","timestamp":1740173007850,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s40615-019-00640-6","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T22:23:13Z","timestamp":1572474193000},"page":"117-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lower Mortality Rates from Cryptococcosis in Women and Whites with Human Immunodeficiency Virus in the United States"],"prefix":"10.1007","volume":"7","author":[{"given":"Giovana","family":"Jaen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4817-5566","authenticated-orcid":false,"given":"Joanna","family":"Drowos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Hennekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"issue":"8","key":"640_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17(8):873\u201381.","journal-title":"Lancet Infect Dis"},{"key":"640_CR2","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at \nhttp:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. Accessed August 15\n\n, 2018."},{"key":"640_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fgb.2015.05.002","volume":"78","author":"A Idnurm","year":"2015","unstructured":"Idnurm A, Lin X. Rising to the challenge of multiple Cryptococcus species and the diseases they cause. Fungal Genet Biol. 2015;78:1\u20136. \nhttps:\/\/doi.org\/10.1016\/j.fgb.2015.05.002\n\n.","journal-title":"Fungal Genet Biol"},{"issue":"5","key":"640_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/0956462417732649","volume":"29","author":"AA Shaheen","year":"2018","unstructured":"Shaheen AA, Somayaji R, Myers R, Mody CH. Epidemiology and trends of cryptococcosis in the United States from 2000-2007: a population-based study. Int J STD AIDS. 2018;29(5):453\u201360.","journal-title":"Int J STD AIDS"},{"issue":"11","key":"640_CR5","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.2105\/AJPH.2009.170795","volume":"100","author":"RS Levine","year":"2010","unstructured":"Levine RS, Rust G, Pisu M, Agboto V, Baltrus P, Briggs NC, et al. Increased Black\/White disparities in mortality following lifesaving innovations: a possible consequence of US federal laws. Am J Public Health. 2010 Nov;100(11):2176\u201384.","journal-title":"Am J Public Health"},{"key":"640_CR6","volume-title":"ICD 10: International Statistical Classification of Diseases and Related Health Problems. Tenth Revision","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. ICD 10: International Statistical Classification of Diseases and Related Health Problems. Tenth Revision. 2nd ed. Geneva: Switzerland; 2004.","edition":"2"},{"issue":"172","key":"640_CR7","first-page":"1","volume":"1","author":"E Arias","year":"2016","unstructured":"Arias E, Heron M, Hakes JK. The validity of race and Hispanic-origin reporting on death certificates in the United States: an update. National Center for Health Statistics. Vital Health Stat. 2016;1(172):1\u201321.","journal-title":"Vital Health Stat"},{"key":"640_CR8","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death: 1999-2016 on CDC WONDER Online Database, released December, 2016. Data are from the Multiple Cause of Death Files, 1999-2015, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Available at URL: \nhttp:\/\/wonder.cdc.gov\/mcd-icd10.html\n\n. Accessed August 20, 2017."},{"issue":"2","key":"640_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/oxfordjournals.epirev.a036195","volume":"17","author":"RA Hajjeh","year":"1995","unstructured":"Hajjeh RA, Brandt ME, Pinner RW. Emergence of cryptococcal disease; epidemiologic perspectives 100 years after its discovery. Epidemiol Rev. 1995;17(2):303\u201320.","journal-title":"Epidemiol Rev"},{"issue":"5","key":"640_CR10","doi-asserted-by":"publisher","first-page":"e63632","DOI":"10.1371\/journal.pone.0063632","volume":"8","author":"EE McClelland","year":"2013","unstructured":"McClelland EE, Hobbs LM, Rivera J, Casadevall A, Potts WK, Smith JM, et al. The role of host gender in the pathogenesis of Cryptococcus neoformans infections. PLoS One. 2013;8(5):e63632.","journal-title":"PLoS One"},{"key":"640_CR11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jama.2011.322","volume":"306","author":"CH Hennekens","year":"2011","unstructured":"Hennekens CH, DeMets D. Statistical association and causation: contributions of different types of evidence. JAMA. 2011;306:1134\u20136.","journal-title":"JAMA"},{"issue":"6","key":"640_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/cid\/ciu937","volume":"60","author":"J McKenney","year":"2015","unstructured":"McKenney J, Bauman S, Neary B, Detels R, et al. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012. Clin Infect Dis. 2015;60(6):959\u201365.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"640_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","volume":"30","author":"Eileen K. Maziarz","year":"2016","unstructured":"Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin N Am. 2016;30(1):179\u2013206. \nhttps:\/\/doi.org\/10.1016\/j.idc.2015.10.006","journal-title":"Infectious Disease Clinics of North America"},{"issue":"10","key":"640_CR14","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3201\/eid1910.130441","volume":"19","author":"JR Harris","year":"2013","unstructured":"Harris JR, Lockhart SR, Sondermeyer G, Vugia DJ, Crist MB, D\u2019Angelo MT, et al. Cryptococcus gattii infections in multiple states outside the US Pacific Northwest. Emerg Infect Dis. 2013 Oct;19(10):1621\u20137.","journal-title":"Emerg Infect Dis"},{"key":"640_CR15","unstructured":"US Centers for Disease Control and Prevention. C. neoformans infection statistics. 2015. Available at URL: \nhttps:\/\/www.cdc.gov\/fungal\/diseases\/cryptococcosis-neoformans\/statistics.html\n\n. Accessed August 29, 2019"},{"key":"640_CR16","unstructured":"Guidelines on the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2018. License: CC BY-NC-SA 3.0 IGO. \nhttp:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/260399\/9789241550277-eng.pdf;jsessionid=063F88E3D9E7F6D02A486D6BB303C15E?sequence=1"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-019-00640-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40615-019-00640-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-019-00640-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:09:45Z","timestamp":1603843785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40615-019-00640-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1007\/s40615-019-00640-6","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"type":"print","value":"2197-3792"},{"type":"electronic","value":"2196-8837"}],"subject":[],"published":{"date-parts":[[2019,10,29]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Ms. Jaen, Dr. Drowos, and Professor Levine report no disclosures.Professor Hennekens reported that he serves as an independent scientist in an advisory role to investigators and sponsors as Chair or Member of Data and Safety Monitoring Boards for Amgen, British Heart Foundation, Cadila, Canadian Institutes of Health Research, DalCor, Regeneron, and the Wellcome Foundation, as well as to the United States (US) Food and Drug Administration, and UpToDate; and receives royalties for authorship or editorship of 3 textbooks and as co-inventor on patents for inflammatory markers and cardiovascular disease that are held by Brigham and Women\u2019s Hospital; and has an investment management relationship with the West-Bacon Group within SunTrust Investment Services, which has discretionary investment authority and does not own any common or preferred stock in any pharmaceutical or medical device company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. The Baylor College of Medicine Institutional Review Board classified this research as exempt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}